Veterinary Medicines

Baycox Sheep, 50 mg/ml oral suspension

Not authorised
  • TOLTRAZURIL
Download as PDF

Product identification

Medicine name:
Baycox Sheep, 50 mg/ml oral suspension
Baycox Sheep vet. 50 mg/ml Mixtúra, dreifa Sauðfé (lömb)
Active substance:
  • TOLTRAZURIL
Target species:
  • Sheep
  • Sheep (lamb)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • TOLTRAZURIL
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        42
        day
    • Sheep (lamb)
      • Meat and offal
        42
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51AJ01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Iceland
Package description:
  • High density polyethylene bottles containing a white or yellowish suspension with a green polypropylene screw cap for the 250 ml and 1000 ml bottle.
  • High density polyethylene bottles containing a white or yellowish suspension with a green polypropylene screw cap for the 250 ml and 1000 ml bottle.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco Animal Health GmbH
Responsible authority:
  • Icelandic Medicines Agency
Authorisation number:
  • IS/2/08/012/01
Date of authorisation status change:
Reference member state:
  • Norway
Procedure number:
  • NO/V/002/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."